May 17, 2020

Telemedicine is booming through increased demands for virtual mobile health services 

Technology
Telemedicine
USA
Telemedicine
Catherine Sturman
2 min
telemedicine
The healthcare industry is becoming increasingly consumer-centric, where health providers are vying to deliver exceptional care which is patient-focused...

The healthcare industry is becoming increasingly consumer-centric, where health providers are vying to deliver exceptional care which is patient-focused and delivers positive patient experiences across the board.

The telemedicine market is part of this drive, where healthcare is steadily adopting a patient-as-consumer model, leading to significant growth. Patients want the ability to access vital healthcare support anytime, anywhere, through face-to-face contact or through digital tools and medical devices at reduced costs.

Tech start-ups, such as HeyDoctor have launched a telemedicine app which will enable physicians to prescribe certain medicines through text messaging – a signal in where the healthcare industry is going.

According to Crystal Market Research, the global telemedicine market is expected to be around $3bn by 2025. The key players are focusing on product innovation and development to introduce next generation products which will assist physicians in remotely interacting with patients more efficiently.

The telemedicine market is especially significant within the US. In Texas, the Medical Board has recently issued a new licensing regulation surrounding the technology, which will emnable physicians to access patients and any potential symptoms through the use of telemedicine, which will be followed up a prescription if needed.

Related stories

The technology will support a growing aging population, and support and improve clinical outcomes. The VA Hospital in San Diego have implemented mHealth technology in tablets to support Veterans’ Affairs doctors in delivering world-class patient care as part of its Anywhere to Anywhere VA Healthcare initiative.

Utilising telemedicine will see the hospital provide increased healthcare access to those who cannot travel on a global scale, which will of course speed up recovery times within the monitoring of wound care and reduce healthcare costs.

“The really great thing about this is that in the past, doctors would have to visually estimate whether a wound has improved based on memory of a past image, which can sometimes be confusing when you also have to remember other patient images as well,” commented Dr. Kevin Broder, Director for the Wound Image Capture and Storage Innovation Project in a story provided by the VA. “This tablet provides recorded, accurate data to track progress.”

Additionally, healthcare provider Kaiser Permanante has been utilising telemedicine within its stroke program Expediting the Process of Evaluating and Stopping Stroke (EXPRESS). The study, which ran from 2015-2016, showed that patient access to treatment and subsequent recovery rates have improved significantly through the use of telemedicine, highlighting its advantages within the transforming industry.

Share article

Jun 23, 2021

Introducing Dosis - the AI powered dosing platform

AI
medication
personalisedmedicine
chronicdisease
3 min
Dosis is an AI-powered personalised medication dosing platform that's on a mission to transform chronic disease management

Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works. 

When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing. 

The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced. 

What is the Strategic Anemia Advisor? 
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease. 

SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool. 

What else is Dosis working on? 
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs. 

What are Dosis' strategic goals for the next 2-3 years? 
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.

What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.

Share article